Dog EIA Borrelia IgG/IgM - antibodies in canine serum
Enzyme immunoassay for the semiquantitative determination of IgG and IgM antibodies to Borrelia burgdorferi in canine serum.
Products specifications
Technology | ELISA |
Sizes | 48/48 tests |
Enzyme immunoassay for the semiquantitative determination of IgG and IgM antibodies to Borrelia burgdorferi in canine serum.
Description:
Microtitre wells are coated with the B. burgdorferi (afzelii) antigen rich in p83, p41(flagelin), p39, OspA, OspC, p18 a p14.
The kit enables 48 tests for the parallel determination of IgG and IgM antibodies, including controls.
The kit may be used sequentially for individual samples.
High sensitivity and specificity.
Total assay time: approximately 1.5 h.
Colour reagents for easy pipetting.
Semiquantitative evaluation using the index of positivity (IP).
The kit includes two types of conjugate: IgG ang IgM.
The kit is manufactured in accordance with Good Manufacturing Practice (GMP).
Shelf life: 24 months.
Application:
Screening test for the detection of acute or chronic infection with B. burgdorferi in dogs.
Checking of therapy results using semiquantitative determination.
Differential diagnosis of non-specific signs and symptoms in dogs, e.g. fever, anorexia, claudication, fatigue, aches, apathy, arthritis, erythema or purulent skin affection, swelling of joints, arthrosis, lymphocytosis, lymphadenopathy, glomerulonephritis, heart block and aggressiveness.